AZ presents strong H1 financial results
The sales numbers were boosted by oncology drugs such as Tagrisso, Imfinzi and Lynparza.
Read More
Tag: financial
GSK Q2 figures boosted by vaccine sales
The company has readjusted its prediction for its earnings per share to decline in the range of -3% to -5% at CER, as opposed to the previous -5% to -9%.
Read More
NHS improvements can’t happen ‘overnight’, says NHS Confederation
The King’s Fund Quarterly Monitoring Report suggested that patients face a long wait before they will see improvements in care as a result of the government’s £20 billion NHS funding boost.
Read More
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
